Preparation of solid lipid nanoparticles and nanostructured lipid carriers for drug delivery and the effects of preparation parameters of solvent injection method

VA Duong, TTL Nguyen, HJ Maeng - Molecules, 2020 - mdpi.com
Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) have emerged as
potential drug delivery systems for various applications that are produced from …

Novel drug delivery systems for loading of natural plant extracts and their biomedical applications

HS Rahman, HH Othman, NI Hammadi… - International journal …, 2020 - Taylor & Francis
Many types of research have distinctly addressed the efficacy of natural plant metabolites
used for human consumption both in cell culture and preclinical animal model systems …

Nanostructured lipid carriers for oral bioavailability enhancement of exemestane: formulation design, in vitro, ex vivo, and in vivo studies

A Singh, YR Neupane, B Mangla, K Kohli - Journal of pharmaceutical …, 2019 - Elsevier
Exemestane (EXE) is a novel oral steroidal aromatase inhibitor approved for the treatment of
breast cancer. However, its oral clinical application is limited because of low aqueous …

Non-animal models of epithelial barriers (skin, intestine and lung) in research, industrial applications and regulatory toxicology.

S Gordon, M Daneshian, J Bouwstra, F Caloni… - …, 2015 - researchonline.ljmu.ac.uk
Models of the outer epithelia of the human body-namely the skin, the intestine and the lung-
have found valid applications in both research and industrial settings as attractive …

[HTML][HTML] PEGylated SLN as a promising approach for lymphatic delivery of gefitinib to lung cancer

AY Sherif, GI Harisa, FK Alanazi, FA Nasr… - International Journal …, 2022 - ncbi.nlm.nih.gov
Purpose The present study aimed to develop gefitinib-loaded solid lipid nanoparticles (GEF-
SLN), and GEF-loaded PEGylated SLN (GEF-P-SLN) for targeting metastatic lung cancer …

Liposome–ligand conjugates: a review on the current state of art

İ Eroğlu, M İbrahim - Journal of drug targeting, 2020 - Taylor & Francis
Early researchers focussed on developing stimuli-responsive liposomes in order to
manipulate drug release at the site of action or under certain conditions. In recent times, a …

Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs

S Banerjee, J Pillai - Expert opinion on drug metabolism & …, 2019 - Taylor & Francis
Introduction: Solid matrix mediated lipid nanoparticle formulations (LNFs) retain some of the
best features of ideal drug carriers necessary for improving the oral absorption and …

Anti HER-2 aptamer functionalized gold nanoparticles of dasatinib for targeted chemo-radiotherapy in breast cancer cells

M Khorshid, J Varshosaz, M Rostami… - Biomaterials …, 2023 - Elsevier
In the present study, gold nanoparticles functionalized with anti HER-2 aptamer were
designed for effective targeted delivery of dasatinib (DSB) to breast cancer cells. Anti HER-2 …

PEGylated liposomes as an emerging therapeutic platform for oral nanomedicine in cancer therapy: In vitro and in vivo assessment

A Singh, YR Neupane, S Shafi, B Mangla… - Journal of molecular …, 2020 - Elsevier
In the rapidly expanding field of nanomedicine, liposomes have been considered as the
most successful drug carrier having various clinically approved products. However, their …

Lipid based nanocarrier system for the potential oral delivery of decitabine: formulation design, characterization, ex vivo, and in vivo assessment

YR Neupane, M Srivastava, N Ahmad, N Kumar… - International journal of …, 2014 - Elsevier
The aim of this study was to design and fabricate nanostructured lipid carrier (NLC) for the
potential oral delivery of decitabine (DCB). NLC was prepared by cold homogenization …